Given that most chemotherapeutic agents and radiotherapy generate PAF agonists and enhance PAFR expression in tumor cells, resulting in tumor cell repopulation, PAF inhibitors or PAFR antagonists have been shown to significantly decrease tumor growth or repopulation [19, 23, 24]. Here, PCLAF is linked to neoplasm.